COVID-19 (SARS-CoV-2 infection) Infections and Infestations
Conditions
Interventions
New admissions (24 hrs) will be screened for eligibility. Recruited subjects will be randomly allocated to either the study or control group.
Study group: Potent disinfectant solution
Sponsors
Hamad Medical Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 years and older 2. COVID-19 reported via positive PCR within 2 weeks of admission 3. Conscious, oriented and can comprehend the study purpose and risks
Exclusion criteria
Exclusion criteria: 1. Pregnancy (females) 2. Intubated (at the time of recruitment) or had any reported cognitive impairment that can prevent proper comprehension of the study or communicating side effects 3. Contra-indication for mouth wash use, e.g. reported allergies to the solution constituents, recent facial/head injuries, maxillofacial conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recovery assessed using clinical improvement along with a negative COVID RT-PCR test at 5 and 15 days of starting treatment 2. Changes in the CT-values of COVID-19 RT-PCR inconclusive test at 5 and 15 days of starting treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Clinical symptoms assessed using the Sore Throat Assessment Tool for the first 5 days 2. COVID progression (ICU intubation vs discharge or transfer to quarantine) recorded by reviewing medical records within the study duration 3. Hospital stay measured using (days) at discharge; or at the end of study for those remained admitted 4. Disposition type (discharged/death) measured using hospital records entries at the time of discharge, or reported mortality during hospital stay | — |
Countries
Qatar
Outcome results
None listed